• 1
    Wang, K. H., Y. H. Lai, J. C. Chang, T. F. Ko, S. L. Shyu and R. Y. Chiou (2005) Germination of peanut kernels to enhance resveratrol biosynthesis and prepare sprouts as a functional vegetable. Agric. Food Chem. 53, 242246.
  • 2
    Kang, H. I., J. Y. Kim, S. J. Kwon, K. W. Park, J. S. Kang and K.I. Seo (2010) Antioxidative effects of peanut sprout extracts. J. Korean Soc. Food Sci. Nutr. 39, 941946.
  • 3
    Bhat, K. P. L., J. W. Kosmeder 2nd and J. M. Pezzuto (2001) Biological effects of resveratrol. Antioxid. Redox Signal. 3, 10411064.
  • 4
    Gusman, J., H. Malonne and G. Atassi (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22, 11111117.
  • 5
    Adhami, V. M., F. Afag and N. Ahmad (2003) Suppression of ultraviolet B exposure-mediated activation of NF-κB in normal human keratinocytes by resveratrol. Neoplasia 5, 7482.
  • 6
    Athar, M., J. H. Back, X. Tang, K. H. Kim, L. Kopelovich, D. R. Bickers and A. L. Kim (2007) Resveratrol: A review of pre-clinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 224, 274283.
  • 7
    Sagai, M. and V. Bocci (2011) Mechanisms of action involved in ozone therapy: Is healing induced via a mild oxidative stress? Med. Gas. Res. 1, 29.
  • 8
    Rautalahi, M. and J. Huttunen (1994) Antioxidants and carcinogenesis. Ann. Med. 26, 435441.
  • 9
    Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J. D. Engel and M. Yamamoto (1999) Keap1 represses nuclear activation of antioxidant response elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 7686.
  • 10
    Black, A., M. K. Gordon, D. E. Heck, M. Gallo, D. L. Laskin and J. D. Laskin (2011) UVB light regulates expression of antioxidant and inflammatory mediators in human corneal epithelial cells. Biochem. Pharmacol. 81, 873880.
  • 11
    Liu, Y., F. Chan, H. Sun, J. Yan, D. Fan, D. Zhao, J. An and D. Zhou (2011) Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression. Eur. J. Pharmacol. 650, 130137.
  • 12
    Piao, M. S., J. J. Park, J. Y. Choi, D. H. Lee, S. J. Yun, J. B. Lee and S. C. Lee (2012) Nrf2-dependent and Nrf2-independent induction of phase 2 detoxifying and antioxidant enzymes during keratinocyte differentiation. Arch. Dermatol. Res. 304, 387395.
  • 13
    Rubiolo, J. A., G. Mithieux and F. V. Vega (2008) Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 59, 6672.
  • 14
    Rubiolo, J. A. and F. V. Vega (2008) Resveratrol protects primary rat hepatocytes against necrosis induced by reactive oxygen species. Biomed. Pharmacother. 62, 606612.
  • 15
    Floreani, M., E. Napoli, L. Quintieri and P. Palatini (2003) Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-disphorase and catalase activities, and protects isolated areata from menadione toxicity. Life Sci. 72, 27412750.
  • 16
    Cao, Z. and Y. Li (2004) Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: Protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 489, 3948.
  • 17
    Piao, M. S., J. Y. Choi, D.H. Lee, S. J. Yun, J. B. Lee and S. C. Lee (2011) Differentiation-dependent expression of NADP(H):quinone oxidoreductase-1 via NF-E2 related factor-2 activation in human epidermal keratinocytes. J. Dermatol. Sci. 62, 147153.
  • 18
    Ciolino, H. P. and G. C. Yeh (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol. 56, 760767.
  • 19
    Revel, A., H. Raanani, E. Younglai, J. Xu, I. Rogers, R. Han, J. F. Savouret and R. F. Casper (2003) Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J. Appl. Toxicol. 23, 255261.
  • 20
    Chow, H. H., L. L. Garland, C. H. Hsu, D. R. Vining, W. M. Chew, J. A. Miller, M. Perloff, J. A. Crowell and D. S. Alberts (2010) Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev. Res. 3, 11681175.
  • 21
    Kim, H. J., J. S. Kang, H. R. Park and Y. I. Hwang (2010) Neuroprotective effects of methanolic extracts from peanut sprouts. J. Life Sci. 20, 253259.
  • 22
    Pascual-Martı́, M. C., A. Salvador, A. Chafer and A. Berna (2001) Supercritical fluid extraction of resveratrol from grape skin of Vitis vinifera and determination by HPLC. Talanta 54, 735740.
  • 23
    Paulo, L., F. Domingues, J. A. Queiroz and E. Galllado (2011) Development and validation of an analytical method for the determination of trans- and cis-resveratrol in wine: analysis of its contents in 186 Portuguese red wines. J. Agric. Food Chem. 59, 21572168.
  • 24
    Bertelli, A. A., L. Giovannini, R. Stradi, A. Bertelli and J. P. Tillement (1996) Plasma and urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tissue React. 18, 6771.
  • 25
    Kaldas, M. I., U. K. Walle and T. Walle (2003) Resveratrol transport and metabolism by human intestinal Caco-2 cells. J. Pharm. Pharmacol. 55, 307312.
  • 26
    Sale, S., R. D. Verschoyle, D. D. J. Jones, N. Wilsher, K. C. Ruparelia, G. A. Potter, P. B. Farmer, W. P. Steward and A. J. Gescher (2004) Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Br. J. Cancer 90, 736744.
  • 27
    Gonzales, A. M. and R. A. Orlando (2009) A Jurkat transcriptional reporter cell line for high-throughput analysis of the nuclear factor-κB signaling pathway. N. Biotechnol. 26, 244250.
  • 28
    Surh, Y. J., K. S. Chun, H. H. Cha, S. S. Han, Y. S. Keum, K. K. Park and S. S. Lee (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res., 480-481, 243268.
  • 29
    Scoditti, E., N. Calabriso, M. Massaro, M. Pellegrino, C. Storelli, G. Martines, R. De Caterina and M. A. Carluccio (2012) Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch. Biochem. Biophys. 527, 8189.
  • 30
    Hung, C. F., Y. K. Lin, Z. R. Huang and J. Y. Fang (2008) Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biol. Pharm. Bull. 31, 955962.
  • 31
    Baur, J. A. and D. A. Sinclair (2006) Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 5, 493506.